Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,447,953
  • Shares Outstanding, K 35,408
  • Annual Sales, $ 860,970 K
  • Annual Income, $ 100,440 K
  • 60-Month Beta 1.32
  • Price/Sales 4.91
  • Price/Cash Flow 31.47
  • Price/Book 5.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.00
  • Number of Estimates 4
  • High Estimate 1.18
  • Low Estimate 0.68
  • Prior Year 0.71
  • Growth Rate Est. (year over year) +40.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.97 +32.11%
on 07/06/20
144.49 -14.08%
on 07/28/20
+30.58 (+32.68%)
since 07/02/20
3-Month
78.23 +58.70%
on 05/05/20
144.49 -14.08%
on 07/28/20
+45.12 (+57.09%)
since 05/04/20
52-Week
58.72 +111.43%
on 03/23/20
144.49 -14.08%
on 07/28/20
+47.67 (+62.33%)
since 08/02/19

Most Recent Stories

More News
Bet on These 5 Low Leverage Stocks This Earnings Season

Debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future. So investors should choose stocks prudently

PDM : 16.22 (+2.01%)
WST : 274.44 (-1.51%)
LAKE : 25.12 (-0.71%)
DSGX : 57.46 (+1.81%)
MEDP : 124.15 (-1.17%)
3 Reasons Why Medpace (MEDP) Is a Great Growth Stock

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

MEDP : 124.15 (-1.17%)
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates (Revised)

Medpace (MEDP) delivered earnings and revenue surprises of 61.90% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MEDP : 124.15 (-1.17%)
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 52.38% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MEDP : 124.15 (-1.17%)
Medpace: 2Q Earnings Snapshot

CINCINNATI (AP) _ Medpace Holdings Inc. (MEDP) on Monday reported second-quarter net income of $24.1 million.

MEDP : 124.15 (-1.17%)
Medpace Holdings, Inc. Reports Second Quarter 2020 Results

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the second quarter ended June 30, 2020.

MEDP : 124.15 (-1.17%)
Is a Surprise Coming for Medpace (MEDP) This Earnings Season?

Medpace (MEDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

MEDP : 124.15 (-1.17%)
Medpace (MEDP) Expected to Beat Earnings Estimates: Should You Buy?

Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEDP : 124.15 (-1.17%)
Medpace Holdings Reaches Analyst Target Price

In recent trading, shares of Medpace Holdings Inc have crossed above the average analyst 12-month target price of $81.67, changing hands for $84.57/share. When a stock reaches the target an analyst has...

MEDP : 124.15 (-1.17%)
Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following two investor conferences in June:

MEDP : 124.15 (-1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MEDP with:

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

2nd Resistance Point 128.02
1st Resistance Point 126.09
Last Price 124.15
1st Support Level 122.66
2nd Support Level 121.17

See More

52-Week High 144.49
Last Price 124.15
Fibonacci 61.8% 111.73
Fibonacci 50% 101.61
Fibonacci 38.2% 91.48
52-Week Low 58.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar